Brand
Samsung Bioepis
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Samsung Bioepis and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-11-05FDA-DrugClass IIHADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01.
Lack of Assurance of Sterility.
Get notified about new Samsung Bioepis recalls
Free weekly digest. We email when a new federal recall affects Samsung Bioepis or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state